市場調査レポート

商品コード

輸液療法市場規模、シェア、成長分析、製品別、適応症別、治療法別、用途別、エンドユーザー別、地域別- 産業予測、2025-2032年

Infusion Therapy Market Size, Share, Growth Analysis, By Product (Infusion Pumps, Infusion Set), By Indication (Cancer, Gastrointestinal Diseases/Disorders), By Therapy, By Application, By End-user, By Region - Industry Forecast 2025-2032

出版日: 2025年01月09日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 779,047円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 911,338円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,043,629円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=146.99円

全表示
概要
目次

概要

サンプル依頼リストに入れる

輸液療法の世界市場規模は2023年に444億5,000万米ドルと評価され、2024年の474億3,000万米ドルから2032年には796億8,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは6.7％で成長する見通しです。

世界の輸液療法市場は、人口の高齢化と慢性疾患の有病率の上昇に後押しされ、大幅な成長を遂げています。輸液や薬剤を血流に直接送り込むこの治療法は、特に抗生物質や化学療法、栄養補給などに迅速で効果的な治療を提供します。患者にとっては、正確な投与と薬効の延長という利点があり、投与回数が減り、外来や在宅での治療が可能になります。その利点にもかかわらず、輸液療法には感染や副作用などのリスクがあり、熟練した管理が必要となります。輸液デバイスの技術的進歩や在宅ヘルスケアへの需要の高まりは、市場拡大を推進する上で極めて重要です。全体として、輸液療法市場は、効率的なヘルスケアソリューションに対するニーズの高まりに対応し、成長態勢を維持しています。

北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ

競合情報

上位5社の比較
主要企業の市場ポジショニング（2024年）
主な市場企業が採用した戦略
市場の最近の動向
企業の市場シェア分析（2024年）
主要企業の企業プロファイル
- 会社概要
- 製品ポートフォリオ分析
- セグメント別シェア分析
- 収益の前年比比較（2022-2024）

主要企業プロファイル

Option Care Health Inc.（United States）
Baxter International Inc.（United States）
ICU Medical, Inc.（United States）
B. Braun Melsungen AG（Germany）
Terumo Corporation（Japan）
Moog Inc.（United States）
Fresenius SE & Co. KGaA（Germany）
Smiths Medical（United Kingdom）
JMS Co. Ltd.（Japan）
Caesarea Medical Electronics（Israel）
CareFusion Corporation（United States）
Poly Medicure Limited（India）
Nipro Corporation（Japan）
Medtronic plc（Ireland）
Becton, Dickinson and Company（BD）（United States）
3M Company（United States）
Teleflex Incorporated（United States）
Edwards Lifesciences Corporation（United States）
Coloplast A/S（Denmark）
Convatec Group plc（United Kingdom）

結論と推奨事項

Product Code: SQMIG35B2080

Global Infusion Therapy Market size was valued at USD 44.45 billion in 2023 and is poised to grow from USD 47.43 billion in 2024 to USD 79.68 billion by 2032, growing at a CAGR of 6.7% during the forecast period (2025-2032).

The global infusion therapy market is witnessing substantial growth, fueled by an aging population and the rising prevalence of chronic diseases. This therapy, which involves the direct delivery of fluids and medications into the bloodstream, provides rapid and effective treatment, particularly for antibiotics, chemotherapy, and nutritional support. Patients benefit from precise dosing and prolonged medication effects, reducing the frequency of administration and enabling outpatient or home treatment options. Despite its advantages, infusion therapy presents risks, including infection and side effects, necessitating skilled administration. Technological advancements in infusion devices and the growing demand for home healthcare are pivotal in driving market expansion. Overall, the infusion therapy market remains poised for growth, addressing the increasing needs for efficient healthcare solutions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Infusion Therapy market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Infusion Therapy Market Segmental Analysis

Global Infusion Therapy Market is segmented by Product, Indication, Therapy, Application, End-user and region. Based on Product, the market is segmented into Infusion Pumps, Infusion Set and Accessories. Based on Indication, the market is segmented into Cancer, Gastrointestinal Diseases/Disorders, Congestive Heart Failure, Rheumatoid Arthritis, Hemophilia, Immune Deficiencies and Others. Based on Therapy, the market is segmented into Antibiotic/Antiviral, Anti-coagulation, Anti-emetics, Blood Component Stimulating Factor, Chemotherapy, Nutrition, Hydration and Pain Management. Based on Application, the market is segmented into Chemotherapy, Diabetes, Gastrointestinal Diseases, Pain management and Others. Based on End-user, the market is segmented into Hospitals, Ambulatory Surgical Centers, Clinics and Homecare Settings. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Infusion Therapy Market

The global infusion therapy market is significantly driven by the rising incidence of chronic illnesses, including cancer, diabetes, and cardiovascular diseases. As these health conditions continue to affect a larger portion of the population, the need for effective treatment options, particularly in the form of infusion therapy products and services, has surged. This growing demand is prompting healthcare providers to expand their infusion therapy offerings, leading to innovations and advancements in technology that enhance patient care. Consequently, the infusion therapy market is experiencing robust growth, fueled by the increasing requirements for targeted and effective treatment strategies for chronic disease management.

Restraints in the Global Infusion Therapy Market

The Global Infusion Therapy market faces significant constraints, primarily due to the elevated expenses linked to infusion therapy products and services. This financial burden poses a major challenge, particularly in developing nations where healthcare access is already restricted. The high costs can limit the adoption and utilization of essential infusion therapies, hindering patient care and overall market growth. As a result, many potential users may be unable to afford the necessary treatments, further exacerbating healthcare inequities and limiting the market's expansion in regions that most require these critical services. Addressing these financial barriers is essential for market advancement.

Market Trends of the Global Infusion Therapy Market

The Global Infusion Therapy market is experiencing a notable shift towards home infusion therapy, driven by an increasing preference among patients for home-based healthcare services. This trend reflects a desire for enhanced convenience, comfort, and cost-efficiency, as patients seek to avoid the hospital environment whenever possible. As a result, healthcare providers are adapting to this demand by offering advanced home infusion solutions, empowering patients with autonomy over their treatment while reducing hospital congestion. The surge in chronic diseases and a growing aging population further bolster this market segment, marking a significant evolution in the delivery of infusion therapies worldwide.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Infusion Therapy Market Size by Product & CAGR (2025-2032)

Market Overview
Infusion Pumps
- Ambulatory Infusion Pumps
- Stationary Infusion Pumps
- Syringe Infusion Pumps
- Disposable Pumps
- Large Volume Pumps
- Elastomeric pumps
Infusion Set
Accessories

Global Infusion Therapy Market Size by Indication & CAGR (2025-2032)

Market Overview
Cancer
Gastrointestinal Diseases/Disorders
Congestive Heart Failure
Rheumatoid Arthritis
Hemophilia
Immune Deficiencies
Others

Global Infusion Therapy Market Size by Therapy & CAGR (2025-2032)

Market Overview
Antibiotic/Antiviral
Anti-coagulation
Anti-emetics
Blood Component Stimulating Factor
Chemotherapy
Nutrition
Hydration
Pain Management

Global Infusion Therapy Market Size by Application & CAGR (2025-2032)

Market Overview
Chemotherapy
Diabetes
Gastrointestinal Diseases
Pain management
Others

Global Infusion Therapy Market Size by End-user & CAGR (2025-2032)

Market Overview
Hospitals
Ambulatory Surgical Centers
Clinics
Homecare Settings

Global Infusion Therapy Market Size & CAGR (2025-2032)

North America (Product, Indication, Therapy, Application, End-user)
- US
- Canada
Europe (Product, Indication, Therapy, Application, End-user)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, Indication, Therapy, Application, End-user)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, Indication, Therapy, Application, End-user)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, Indication, Therapy, Application, End-user)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Option Care Health Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Baxter International Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ICU Medical, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
B. Braun Melsungen AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Moog Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fresenius SE & Co. KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Smiths Medical (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
JMS Co. Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Caesarea Medical Electronics (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CareFusion Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Poly Medicure Limited (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nipro Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (BD) (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
3M Company (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teleflex Incorporated (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Edwards Lifesciences Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Coloplast A/S (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Convatec Group plc (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

輸液療法市場規模、シェア、成長分析、製品別、適応症別、治療法別、用途別、エンドユーザー別、地域別- 産業予測、2025-2032年

Infusion Therapy Market Size, Share, Growth Analysis, By Product (Infusion Pumps, Infusion Set), By Indication (Cancer, Gastrointestinal Diseases/Disorders), By Therapy, By Application, By End-user, By Region - Industry Forecast 2025-2032

目次

イントロダクション

調査手法

エグゼクティブサマリー

市場力学と見通し

主な市場の考察

輸液療法市場規模：製品別

輸液療法市場規模：適応症別

輸液療法市場規模：治療法別

輸液療法市場規模：用途別

輸液療法市場規模：エンドユーザー別

輸液療法市場規模